1 hr 48 min
The Victor Brooks Show Episode 48 (Quarantine Series) Dr. Milton Brown The Victor Brooks Show
-
- Music Interviews
Brown currently serves as Professor of Practice and Director for the Center for Drug Discovery for Rare and Underserved Diseases at George Mason University in Fairfax, Virginia and Fellow at the National Academy of Inventors (FNAI). His distinguished career has led to his international recognition as a leader in drug discovery and development research.
“We are excited to have Dr. Brown join our Board, bringing his unique talents, expertise and perspectives to FARE and the 32 million Americans living with potentially life-threatening food allergies,” said David G. Bunning, chairman of the Board of Directors for FARE. “Dr. Brown’s passion for medicine is clear, and we know this passion will aid us in our mission to find a cure for food allergies and improve the lives of all those affected.”
Dr. Brown is a recipient of the 2015 Percy Julian Award by the National Organization of Black Chemists and Chemical Engineers for significant contributions in pure and/or applied research in science and has served as a scientific reviewer of grants and programs for the National Institutes of Health (NIH), National Cancer Institute (NCI) Cancer Center Support Grants, Department of Defense (DOD) and the American Association for the Advancement of Science (AAAS). Brown previously served as Deputy Director for Drug Discovery & Development at the Inova Schar Cancer Institute and Director of the Inova Schar Cancer Center for Drug Discovery at Inova Center for Personalized Health in Fairfax, Virginia.
In addition to his role on FARE’s Board of Directors, Brown will also serve as a co-chair of FARE’s Voice of the Patient Roundtable: Diversity, Equity & Inclusion. The Roundtable, which is set to be scheduled this fall, is co-chaired by Michael Frazier, FARE Board of National Ambassadors and Advocacy Advisory Committee member, and seeks to bring thought leaders together to find consensus on how patient advocacy organizations can advance diversity, equity and inclusion (DEI) in the work that they do. Following the event, FARE will publish a blueprint outlining actionable steps to address DEI in food allergy education and research.
“In identifying leaders who can play a key role in moving food allergy science and advocacy forward, Dr. Brown stood out as a seasoned professional who has a track record for developing trust in the community and with grateful patients and in maintaining multi-investigator collaborations in academia and industry, locally, nationally and internationally,” said Lisa Gable, chief executive officer for FARE. “We are thrilled to have him join our board and look forward to all we will be able to do together.”
Brown currently serves as Professor of Practice and Director for the Center for Drug Discovery for Rare and Underserved Diseases at George Mason University in Fairfax, Virginia and Fellow at the National Academy of Inventors (FNAI). His distinguished career has led to his international recognition as a leader in drug discovery and development research.
“We are excited to have Dr. Brown join our Board, bringing his unique talents, expertise and perspectives to FARE and the 32 million Americans living with potentially life-threatening food allergies,” said David G. Bunning, chairman of the Board of Directors for FARE. “Dr. Brown’s passion for medicine is clear, and we know this passion will aid us in our mission to find a cure for food allergies and improve the lives of all those affected.”
Dr. Brown is a recipient of the 2015 Percy Julian Award by the National Organization of Black Chemists and Chemical Engineers for significant contributions in pure and/or applied research in science and has served as a scientific reviewer of grants and programs for the National Institutes of Health (NIH), National Cancer Institute (NCI) Cancer Center Support Grants, Department of Defense (DOD) and the American Association for the Advancement of Science (AAAS). Brown previously served as Deputy Director for Drug Discovery & Development at the Inova Schar Cancer Institute and Director of the Inova Schar Cancer Center for Drug Discovery at Inova Center for Personalized Health in Fairfax, Virginia.
In addition to his role on FARE’s Board of Directors, Brown will also serve as a co-chair of FARE’s Voice of the Patient Roundtable: Diversity, Equity & Inclusion. The Roundtable, which is set to be scheduled this fall, is co-chaired by Michael Frazier, FARE Board of National Ambassadors and Advocacy Advisory Committee member, and seeks to bring thought leaders together to find consensus on how patient advocacy organizations can advance diversity, equity and inclusion (DEI) in the work that they do. Following the event, FARE will publish a blueprint outlining actionable steps to address DEI in food allergy education and research.
“In identifying leaders who can play a key role in moving food allergy science and advocacy forward, Dr. Brown stood out as a seasoned professional who has a track record for developing trust in the community and with grateful patients and in maintaining multi-investigator collaborations in academia and industry, locally, nationally and internationally,” said Lisa Gable, chief executive officer for FARE. “We are thrilled to have him join our board and look forward to all we will be able to do together.”
1 hr 48 min